organic compounds
(1′S,6′S,8′S,9′R)-9′-Bromo-12′-oxaspiro[1,3-dioxolane-2,4′-tricyclo[6.3.1.01,6]dodecane]
aDepartment of Organic Chemistry, Indian Institute of Science, Bangalore 560 012, Karnataka, India, and bSchool of Chemistry, University of Hyderabad, Hyderabad 500 046, A.P. India
*Correspondence e-mail: gmsc@uohyd.ernet.in, gm@orgchem.iisc.ernet.in
In an endeavor directed towards the construction of the oxabicyclic[3.2.1]octane segment present in the bioactive natural products of cortistatins and icetexanes genre, the title compound, C13H19BrO3, was synthesized from (4aR,9aS)-1,3,4,4a,5,6,9,9a-octahydrospiro[benzo[7]annulene-2,2′-[1,3]dioxolane]-4a-ol via a transannular bromo-etherification protocol. The six-membered ring adopts a twist-boat conformation, while the fused cycloheptane ring adopts a chair conformation. The crystal packing is effected through two distinct intermolecular C—H⋯O hydrogen-bond patterns and molecules are arranged to define an interesting motif along the b axis.
Related literature
For the isolation and biological activity of cortistatins, see: Aoki et al. (2006, 2007); Watanabe et al. (2007); Zhao (2010) and for icetexanes, see: Esquivel et al. (1995); Uchiyama et al. (2005). For synthetic approaches towards the construction of the oxabicyclic core of cortistatins, see: Zhao (2010); Hardin Narayan et al. (2010) and references cited therein. For their use in the treatment of blindness, see: Czako et al. (2009). For the construction of relevant 6/7 fused-ring systems involving ring-closing metathesis, see: Mehta & Likhite (2008, 2009). For an example of the exploitation of transannular bromoetherification towards natural products synthesis, see: Mehta & Sen (2010); Mehta & Yaragorla (2011).
Experimental
Crystal data
|
Refinement
|
Data collection: APEX2 (Bruker, 2008); cell SAINT (Bruker, 2008); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL.
Supporting information
https://doi.org/10.1107/S1600536812029777/ds2204sup1.cif
contains datablocks I, global. DOI:Structure factors: contains datablock I. DOI: https://doi.org/10.1107/S1600536812029777/ds2204Isup2.hkl
Supporting information file. DOI: https://doi.org/10.1107/S1600536812029777/ds2204Isup3.cml
The synthesis of the title compound 3 as depicted in Fig. 2 emanates from the known 7-(prop-2-en-1-yl)-1,4-dioxaspiro[4.5]decan-8-one 5 through addition of butenylmagnesium bromide (1.5 equiv.) in THF at r.t. to furnish the desired RCM precursor 6 in decent yield. Exposure of 6 to Grubbs-1s t generation catalyst (10 mol%) in benzene at r.t. gave the bicyclic compound 7 in good yield. Finally, the stepwise transannular bromotherification on 7 was executed via bromination with pyH+Br3- (1.2 equiv.) in DCM at 0 °C followed by etherification in the presence of 10 M aq. NaOH in THF at 60 °C for 4 h to deliver 3, mp. 78–80 °C, as a colorless crystalline compound in 51% yield.
All the non-hydrogen atoms were refined anisotropically. Hydrogen atoms on the C atoms were introduced on calculated positions and were included in the
riding on their respective parent atomsThe oxabicyclic[3,2,1]octane scaffold manifest itself in a variety of
class of natural products viz. icetexanes (Fig. 1; Esquivel et al., 1995 & Uchiyama et al., 2005) and cortistatin family (Fig. 1; Aoki et al., 2006, 2007 & Watanabe et al., 2007). In particular, cortistatin A and its structural siblings isolated in trace amounts by Kobayashi & coworkers from an Indonesian marine sponge corticium simplex were shown to possess novel architecture and exhibited potent and promising anti-angiogenic activity (Zhao, 2010) and were effective in treating blindness (Czako et al., 2009), thereby triggering interest to devise tactics for their total synthesis and diversity creation. These attributes of cortistatins encouraged us to devise a strategy to gain rapid access to the oxatricyclic ABC core present in cortistatins.Several synthetic approaches to cortistatins have been reported utilizing ring-expansion approach, oxidative dearomatization, electrocyclization, 1,3-dipolar cycloaddition/electrocyclization cascade, transannular [4 + 3]
classical Michael/aldol condensation cascade as the key strategic steps to access the oxatricyclic segment (Hardin Narayan et al., 2010). However, the present strategy employs a stepwise transannular bromoetherification sequence (Mehta & Sen, 2010; Mehta & Yaragorla, 2011) on a readily accessible bicyclic compound obtained via RCM (Fig. 2; Mehta & Likhite, 2008, 2009).A two step transannular bromoetherification protocol on 7 furnished the title compound 3 (Fig. 2) as the major product corresponding to the oxatricyclic core present in icetexanes along with a minor regioisomeric compound 4 representing the oxatricyclic segment present in cortistatins.
The title compound 3 was crystallized from ethylacetate-hexane(1:1) and the structure was solved and refined in monoclinic P21/c
with one molecule of 3 in the An ORTEP diagram of 3 drawn at 30% ellipsoidal probability is depicted in Fig 3. From the packing diagram it can be seen that the centrosymmetric molecules are connected by weak C11–H11···O2 (2.53 Å, 156°) hydrogen bonds forming a dimeric motif and these dimeric units are further connected by C1–H1···O1 (2.57 Å, 153°)) hydrogen bonds, three dimensionally (Fig. 4).These two hydrogen bond patterns link the molecules to define an interesting motif along the b axis.For the isolation and biological activity of cortistatins, see: Aoki et al. (2006, 2007); Watanabe et al. (2007); Zhao (2010) and for icetexanes, see: Esquivel et al. (1995); Uchiyama et al. (2005). For synthetic approaches towards the construction of the oxabicyclic core of cortistatins, see: Zhao (2010); Hardin Narayan et al. (2010) and references cited therein. For their use in the treatment of blindness, see: Czako et al. (2009). For the construction of relevant 6/7 fused-ring systems involving ring-closing metathesis, see: Mehta & Likhite (2008, 2009). For an example of the exploitation of transannular bromoetherification towards natural products synthesis, see: Mehta & Sen (2010); Mehta & Yaragorla (2011).
Data collection: APEX2 (Bruker, 2008); cell
SAINT (Bruker, 2008); data reduction: SAINT (Bruker, 2008); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL (Sheldrick, 2008).C13H19BrO3 | F(000) = 624 |
Mr = 303.19 | Dx = 1.577 Mg m−3 |
Monoclinic, P21/c | Mo Kα radiation, λ = 0.71073 Å |
Hall symbol: -P 2ybc | Cell parameters from 4277 reflections |
a = 11.0159 (3) Å | θ = 2.6–24.2° |
b = 12.6619 (3) Å | µ = 3.21 mm−1 |
c = 10.2763 (2) Å | T = 296 K |
β = 117.044 (1)° | Block, colorless |
V = 1276.63 (5) Å3 | 0.30 × 0.20 × 0.15 mm |
Z = 4 |
Bruker APEXII CCD diffractometer | 2368 independent reflections |
Radiation source: fine-focus sealed tube | 1859 reflections with I > 2σ(I) |
Graphite monochromator | Rint = 0.027 |
φ and ω scans | θmax = 25.4°, θmin = 2.1° |
Absorption correction: multi-scan (SADABS; Bruker, 2008) | h = −13→12 |
Tmin = 0.446, Tmax = 0.644 | k = −15→14 |
11338 measured reflections | l = −9→12 |
Refinement on F2 | Primary atom site location: structure-invariant direct methods |
Least-squares matrix: full | Secondary atom site location: difference Fourier map |
R[F2 > 2σ(F2)] = 0.030 | Hydrogen site location: inferred from neighbouring sites |
wR(F2) = 0.076 | w = 1/[σ2(Fo2) + (0.0436P)2 + 0.2892P] where P = (Fo2 + 2Fc2)/3 |
S = 1.02 | (Δ/σ)max = 0.001 |
2368 reflections | Δρmax = 0.25 e Å−3 |
154 parameters | Δρmin = −0.32 e Å−3 |
0 restraints |
C13H19BrO3 | V = 1276.63 (5) Å3 |
Mr = 303.19 | Z = 4 |
Monoclinic, P21/c | Mo Kα radiation |
a = 11.0159 (3) Å | µ = 3.21 mm−1 |
b = 12.6619 (3) Å | T = 296 K |
c = 10.2763 (2) Å | 0.30 × 0.20 × 0.15 mm |
β = 117.044 (1)° |
Bruker APEXII CCD diffractometer | 2368 independent reflections |
Absorption correction: multi-scan (SADABS; Bruker, 2008) | 1859 reflections with I > 2σ(I) |
Tmin = 0.446, Tmax = 0.644 | Rint = 0.027 |
11338 measured reflections |
R[F2 > 2σ(F2)] = 0.030 | 154 parameters |
wR(F2) = 0.076 | 0 restraints |
S = 1.02 | Δρmax = 0.25 e Å−3 |
2368 reflections | Δρmin = −0.32 e Å−3 |
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. |
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger. |
x | y | z | Uiso*/Ueq | ||
Br1 | 0.70444 (3) | 0.11259 (2) | 0.71170 (3) | 0.06222 (13) | |
O1 | 0.66345 (15) | 0.35583 (12) | 0.61783 (15) | 0.0391 (4) | |
O2 | 0.7122 (2) | 0.73040 (14) | 0.57865 (18) | 0.0640 (5) | |
O3 | 0.84162 (18) | 0.72842 (13) | 0.82550 (18) | 0.0529 (4) | |
C1 | 0.6947 (2) | 0.24005 (18) | 0.8181 (2) | 0.0424 (5) | |
H1 | 0.6541 | 0.2205 | 0.8820 | 0.051* | |
C11 | 0.6034 (2) | 0.32101 (18) | 0.7079 (2) | 0.0404 (5) | |
H11 | 0.5125 | 0.2915 | 0.6480 | 0.048* | |
C13 | 0.7789 (3) | 0.8290 (2) | 0.7886 (3) | 0.0547 (7) | |
H13A | 0.8441 | 0.8848 | 0.8377 | 0.066* | |
H13B | 0.7043 | 0.8344 | 0.8138 | 0.066* | |
C4 | 0.7757 (2) | 0.42229 (17) | 0.7136 (2) | 0.0348 (5) | |
C2 | 0.8358 (2) | 0.2838 (2) | 0.9109 (3) | 0.0479 (6) | |
H2A | 0.8985 | 0.2259 | 0.9566 | 0.057* | |
H2B | 0.8345 | 0.3275 | 0.9878 | 0.057* | |
C7 | 0.7737 (2) | 0.66148 (18) | 0.7019 (2) | 0.0439 (5) | |
C5 | 0.8222 (3) | 0.48727 (18) | 0.6187 (3) | 0.0482 (6) | |
H5A | 0.8906 | 0.4482 | 0.6038 | 0.058* | |
H5B | 0.7453 | 0.4997 | 0.5239 | 0.058* | |
C3 | 0.8863 (2) | 0.34948 (19) | 0.8204 (3) | 0.0439 (5) | |
H3A | 0.9638 | 0.3916 | 0.8854 | 0.053* | |
H3B | 0.9165 | 0.3025 | 0.7663 | 0.053* | |
C9 | 0.7113 (2) | 0.49168 (18) | 0.7904 (2) | 0.0371 (5) | |
H9 | 0.7779 | 0.5045 | 0.8922 | 0.044* | |
C8 | 0.6607 (2) | 0.59613 (19) | 0.7111 (3) | 0.0463 (6) | |
H8A | 0.6205 | 0.6371 | 0.7613 | 0.056* | |
H8B | 0.5900 | 0.5822 | 0.6130 | 0.056* | |
C6 | 0.8809 (3) | 0.59178 (19) | 0.6909 (3) | 0.0510 (6) | |
H6A | 0.9192 | 0.6282 | 0.6350 | 0.061* | |
H6B | 0.9540 | 0.5790 | 0.7881 | 0.061* | |
C12 | 0.7281 (3) | 0.8340 (2) | 0.6265 (3) | 0.0637 (7) | |
H12A | 0.6419 | 0.8713 | 0.5805 | 0.076* | |
H12B | 0.7934 | 0.8703 | 0.6032 | 0.076* | |
C10 | 0.5940 (2) | 0.4216 (2) | 0.7848 (3) | 0.0467 (6) | |
H10A | 0.6061 | 0.4061 | 0.8825 | 0.056* | |
H10B | 0.5065 | 0.4560 | 0.7300 | 0.056* |
U11 | U22 | U33 | U12 | U13 | U23 | |
Br1 | 0.0895 (3) | 0.04123 (17) | 0.0633 (2) | −0.00573 (13) | 0.04119 (18) | −0.00022 (12) |
O1 | 0.0431 (9) | 0.0423 (8) | 0.0294 (8) | −0.0076 (7) | 0.0142 (7) | −0.0022 (6) |
O2 | 0.0890 (14) | 0.0478 (10) | 0.0373 (10) | −0.0019 (10) | 0.0129 (10) | 0.0008 (8) |
O3 | 0.0545 (10) | 0.0443 (9) | 0.0425 (9) | 0.0021 (8) | 0.0068 (8) | −0.0056 (7) |
C1 | 0.0489 (14) | 0.0453 (13) | 0.0364 (12) | −0.0032 (10) | 0.0223 (11) | 0.0011 (10) |
C11 | 0.0321 (12) | 0.0482 (13) | 0.0380 (13) | −0.0066 (10) | 0.0134 (10) | 0.0023 (10) |
C13 | 0.0602 (17) | 0.0420 (14) | 0.0590 (17) | −0.0012 (12) | 0.0246 (14) | −0.0077 (12) |
C4 | 0.0335 (12) | 0.0383 (11) | 0.0327 (12) | −0.0032 (9) | 0.0153 (10) | −0.0047 (10) |
C2 | 0.0453 (14) | 0.0514 (14) | 0.0364 (13) | 0.0075 (11) | 0.0094 (11) | 0.0049 (11) |
C7 | 0.0488 (14) | 0.0384 (12) | 0.0372 (13) | −0.0014 (11) | 0.0132 (11) | −0.0032 (10) |
C5 | 0.0584 (16) | 0.0430 (13) | 0.0569 (15) | −0.0040 (11) | 0.0382 (13) | −0.0051 (11) |
C3 | 0.0313 (12) | 0.0458 (12) | 0.0504 (14) | 0.0011 (10) | 0.0149 (11) | −0.0047 (11) |
C9 | 0.0325 (12) | 0.0443 (12) | 0.0337 (12) | 0.0026 (9) | 0.0144 (10) | −0.0042 (10) |
C8 | 0.0370 (12) | 0.0462 (14) | 0.0493 (15) | 0.0067 (10) | 0.0140 (11) | −0.0024 (11) |
C6 | 0.0516 (15) | 0.0453 (14) | 0.0621 (16) | −0.0098 (11) | 0.0311 (13) | −0.0067 (12) |
C12 | 0.075 (2) | 0.0490 (16) | 0.0596 (17) | 0.0066 (14) | 0.0237 (15) | 0.0063 (13) |
C10 | 0.0399 (13) | 0.0549 (14) | 0.0508 (14) | 0.0033 (11) | 0.0255 (12) | 0.0035 (12) |
Br1—C1 | 1.979 (2) | C2—H2B | 0.9700 |
O1—C11 | 1.430 (3) | C7—C6 | 1.519 (3) |
O1—C4 | 1.449 (3) | C7—C8 | 1.533 (4) |
O2—C12 | 1.384 (3) | C5—C6 | 1.511 (3) |
O2—C7 | 1.430 (3) | C5—H5A | 0.9700 |
O3—C13 | 1.416 (3) | C5—H5B | 0.9700 |
O3—C7 | 1.424 (3) | C3—H3A | 0.9700 |
C1—C2 | 1.512 (3) | C3—H3B | 0.9700 |
C1—C11 | 1.519 (3) | C9—C8 | 1.520 (3) |
C1—H1 | 0.9800 | C9—C10 | 1.547 (3) |
C11—C10 | 1.528 (3) | C9—H9 | 0.9800 |
C11—H11 | 0.9800 | C8—H8A | 0.9700 |
C13—C12 | 1.498 (4) | C8—H8B | 0.9700 |
C13—H13A | 0.9700 | C6—H6A | 0.9700 |
C13—H13B | 0.9700 | C6—H6B | 0.9700 |
C4—C3 | 1.524 (3) | C12—H12A | 0.9700 |
C4—C5 | 1.531 (3) | C12—H12B | 0.9700 |
C4—C9 | 1.552 (3) | C10—H10A | 0.9700 |
C2—C3 | 1.529 (3) | C10—H10B | 0.9700 |
C2—H2A | 0.9700 | ||
C11—O1—C4 | 104.04 (15) | C4—C5—H5A | 109.5 |
C12—O2—C7 | 109.37 (19) | C6—C5—H5B | 109.5 |
C13—O3—C7 | 107.58 (18) | C4—C5—H5B | 109.5 |
C2—C1—C11 | 111.43 (19) | H5A—C5—H5B | 108.1 |
C2—C1—Br1 | 110.40 (16) | C4—C3—C2 | 111.99 (18) |
C11—C1—Br1 | 108.80 (15) | C4—C3—H3A | 109.2 |
C2—C1—H1 | 108.7 | C2—C3—H3A | 109.2 |
C11—C1—H1 | 108.7 | C4—C3—H3B | 109.2 |
Br1—C1—H1 | 108.7 | C2—C3—H3B | 109.2 |
O1—C11—C1 | 110.25 (17) | H3A—C3—H3B | 107.9 |
O1—C11—C10 | 103.78 (17) | C8—C9—C10 | 112.51 (19) |
C1—C11—C10 | 110.77 (19) | C8—C9—C4 | 111.12 (18) |
O1—C11—H11 | 110.6 | C10—C9—C4 | 102.94 (18) |
C1—C11—H11 | 110.6 | C8—C9—H9 | 110.0 |
C10—C11—H11 | 110.6 | C10—C9—H9 | 110.0 |
O3—C13—C12 | 103.1 (2) | C4—C9—H9 | 110.0 |
O3—C13—H13A | 111.2 | C9—C8—C7 | 113.1 (2) |
C12—C13—H13A | 111.2 | C9—C8—H8A | 108.9 |
O3—C13—H13B | 111.2 | C7—C8—H8A | 108.9 |
C12—C13—H13B | 111.2 | C9—C8—H8B | 108.9 |
H13A—C13—H13B | 109.1 | C7—C8—H8B | 108.9 |
O1—C4—C3 | 107.08 (17) | H8A—C8—H8B | 107.8 |
O1—C4—C5 | 107.98 (17) | C5—C6—C7 | 111.8 (2) |
C3—C4—C5 | 113.22 (18) | C5—C6—H6A | 109.3 |
O1—C4—C9 | 103.17 (16) | C7—C6—H6A | 109.3 |
C3—C4—C9 | 112.15 (18) | C5—C6—H6B | 109.3 |
C5—C4—C9 | 112.49 (18) | C7—C6—H6B | 109.3 |
C1—C2—C3 | 111.68 (18) | H6A—C6—H6B | 107.9 |
C1—C2—H2A | 109.3 | O2—C12—C13 | 106.1 (2) |
C3—C2—H2A | 109.3 | O2—C12—H12A | 110.5 |
C1—C2—H2B | 109.3 | C13—C12—H12A | 110.5 |
C3—C2—H2B | 109.3 | O2—C12—H12B | 110.5 |
H2A—C2—H2B | 107.9 | C13—C12—H12B | 110.5 |
O3—C7—O2 | 105.78 (18) | H12A—C12—H12B | 108.7 |
O3—C7—C6 | 107.5 (2) | C11—C10—C9 | 104.20 (17) |
O2—C7—C6 | 111.1 (2) | C11—C10—H10A | 110.9 |
O3—C7—C8 | 112.2 (2) | C9—C10—H10A | 110.9 |
O2—C7—C8 | 108.2 (2) | C11—C10—H10B | 110.9 |
C6—C7—C8 | 111.80 (19) | C9—C10—H10B | 110.9 |
C6—C5—C4 | 110.50 (19) | H10A—C10—H10B | 108.9 |
C6—C5—H5A | 109.5 |
D—H···A | D—H | H···A | D···A | D—H···A |
C11—H11···O2i | 0.98 | 2.53 | 3.445 (3) | 156 |
C1—H1···O1ii | 0.98 | 2.57 | 3.471 (3) | 153 |
Symmetry codes: (i) −x+1, −y+1, −z+1; (ii) x, −y+1/2, z+1/2. |
Experimental details
Crystal data | |
Chemical formula | C13H19BrO3 |
Mr | 303.19 |
Crystal system, space group | Monoclinic, P21/c |
Temperature (K) | 296 |
a, b, c (Å) | 11.0159 (3), 12.6619 (3), 10.2763 (2) |
β (°) | 117.044 (1) |
V (Å3) | 1276.63 (5) |
Z | 4 |
Radiation type | Mo Kα |
µ (mm−1) | 3.21 |
Crystal size (mm) | 0.30 × 0.20 × 0.15 |
Data collection | |
Diffractometer | Bruker APEXII CCD |
Absorption correction | Multi-scan (SADABS; Bruker, 2008) |
Tmin, Tmax | 0.446, 0.644 |
No. of measured, independent and observed [I > 2σ(I)] reflections | 11338, 2368, 1859 |
Rint | 0.027 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.030, 0.076, 1.02 |
No. of reflections | 2368 |
No. of parameters | 154 |
Δρmax, Δρmin (e Å−3) | 0.25, −0.32 |
Computer programs: APEX2 (Bruker, 2008), SAINT (Bruker, 2008), SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), SHELXTL (Sheldrick, 2008).
D—H···A | D—H | H···A | D···A | D—H···A |
C11—H11···O2i | 0.98 | 2.53 | 3.445 (3) | 156.0 |
C1—H1···O1ii | 0.98 | 2.57 | 3.471 (3) | 153.3 |
Symmetry codes: (i) −x+1, −y+1, −z+1; (ii) x, −y+1/2, z+1/2. |
Acknowledgements
TBK thanks the University Grants Commission, India for the award of Dr Kothari post-doctoral fellowship. We thank Mr Saikat Sen for his help in determining the X-ray
at the CCD facility of the Indian Institute of Science (IISc), Bangalore. GM acknowledges the research support from Eli Lilly and Jubilant-Bhartia Foundations.References
Aoki, S., Watanabe, Y., Sanagawa, M., Setiawan, A., Kotoku, N. & Kobayashi, M. (2006). J. Am. Chem. Soc. 128, 3148–3149. Web of Science CSD CrossRef PubMed CAS Google Scholar
Aoki, S., Watanabe, Y., Tanabe, D., Setiawan, A., Arai, M. & Kobayashi, M. (2007). Tetrahedron Lett. 48, 4485–4488. Web of Science CrossRef CAS Google Scholar
Bruker (2008). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA. Google Scholar
Czako, B., Kurti, L., Mammoto, A., Ingber, D. E. & Corey, E. J. (2009). J. Am. Chem. Soc. 131, 9014–9015. Web of Science PubMed CAS Google Scholar
Esquivel, B., Flores, M., Hernandez-Ortega, S., Toscano, R. A. & Ramamoorthy, T. P. (1995). Phytochemistry, 39, 139–143. CSD CrossRef CAS Web of Science Google Scholar
Hardin Narayan, A. R., Simmons, E. M. & Sarpong, R. (2010). Eur. J. Org. Chem. pp. 3553–3567. Web of Science CrossRef Google Scholar
Mehta, G. & Likhite, N. S. (2008). Tetrahedron Lett. 49, 7113–7116. Web of Science CSD CrossRef CAS Google Scholar
Mehta, G. & Likhite, N. S. (2009). Tetrahedron Lett. 50, 5263–5266. Web of Science CSD CrossRef CAS Google Scholar
Mehta, G. & Sen, S. (2010). Tetrahedron Lett. 51, 503–507. Web of Science CSD CrossRef CAS Google Scholar
Mehta, G. & Yaragorla, S. (2011). Tetrahedron Lett. 52, 4485–4489. Web of Science CSD CrossRef CAS Google Scholar
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Web of Science CrossRef CAS IUCr Journals Google Scholar
Uchiyama, N., Kabututu, Z., Kubata, B. K., Kiuchi, F., Ito, M., Nakajima-Shimada, J., Aoki, T., Ohkubo, K., Fukuzumi, S., Martin, S. K., Honda, G. & Urade, Y. (2005). Antimicrob. Agents Chemother. 49, 5123–5126. Web of Science CrossRef PubMed CAS Google Scholar
Watanabe, Y., Aoki, S., Tanabe, D., Setiawan, A. & Kobayashi, M. (2007). Tetrahedron, 63, 4074–4079. Web of Science CrossRef CAS Google Scholar
Zhao, W. (2010). Chem. Rev. 110, 1706–1745. Web of Science CrossRef PubMed CAS Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
The oxabicyclic[3,2,1]octane scaffold manifest itself in a variety of terpenoids class of natural products viz. icetexanes (Fig. 1; Esquivel et al., 1995 & Uchiyama et al., 2005) and cortistatin family (Fig. 1; Aoki et al., 2006, 2007 & Watanabe et al., 2007). In particular, cortistatin A and its structural siblings isolated in trace amounts by Kobayashi & coworkers from an Indonesian marine sponge corticium simplex were shown to possess novel architecture and exhibited potent and promising anti-angiogenic activity (Zhao, 2010) and were effective in treating blindness (Czako et al., 2009), thereby triggering interest to devise tactics for their total synthesis and diversity creation. These attributes of cortistatins encouraged us to devise a strategy to gain rapid access to the oxatricyclic ABC core present in cortistatins.
Several synthetic approaches to cortistatins have been reported utilizing ring-expansion approach, oxidative dearomatization, electrocyclization, 1,3-dipolar cycloaddition/electrocyclization cascade, transannular [4 + 3] cycloaddition, classical Michael/aldol condensation cascade cyclization as the key strategic steps to access the oxatricyclic segment (Hardin Narayan et al., 2010). However, the present strategy employs a stepwise transannular bromoetherification sequence (Mehta & Sen, 2010; Mehta & Yaragorla, 2011) on a readily accessible bicyclic compound obtained via RCM (Fig. 2; Mehta & Likhite, 2008, 2009).
A two step transannular bromoetherification protocol on 7 furnished the title compound 3 (Fig. 2) as the major product corresponding to the oxatricyclic core present in icetexanes along with a minor regioisomeric compound 4 representing the oxatricyclic segment present in cortistatins.
The title compound 3 was crystallized from ethylacetate-hexane(1:1) and the structure was solved and refined in monoclinic P21/c space group with one molecule of 3 in the asymmetric unit. An ORTEP diagram of 3 drawn at 30% ellipsoidal probability is depicted in Fig 3. From the packing diagram it can be seen that the centrosymmetric molecules are connected by weak C11–H11···O2 (2.53 Å, 156°) hydrogen bonds forming a dimeric motif and these dimeric units are further connected by C1–H1···O1 (2.57 Å, 153°)) hydrogen bonds, three dimensionally (Fig. 4).These two hydrogen bond patterns link the molecules to define an interesting motif along the b axis.